MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles

Assaf A. Gilad, Piotr Walczak, Michael T. McMahon, Bin Na Hyon, Hee Lee Jung, Kwangjin An, Taegwhan Hyeon, Peter C.M. Van Zijl, Jeff W.M. Bulte

Research output: Contribution to journalArticlepeer-review

135 Scopus citations


Rat glioma cells were labeled using electroporation with either manganese oxide (MnO) or superparamagnetic iron oxide (SPIO) nanoparticles. The viability and proliferation of SPIO-labeled cells (1.9 mg Fe/ml) or cells electroporated with a low dose of MnO (100 μg Mn/ml) was not significantly different from unlabeled cells; a higher MnO dose (785 μg Mn/ml) was found to be toxic. The cellular ion content was 0.1-0.3 pg Mn/cell and 4.4 pg Fe/cell, respectively, with cellular relaxivities of 2.5-4.8 s-1 (R1) and 45-84 s-1 (R2) for MnO-labeled cells. Labeled cells (SPIO and low-dose MnO) were each transplanted in contralateral brain hemispheres of rats and imaged in vivo at 9.4T. While SPIO-labeled cells produced a strong "negative contrast" due to the increase in R2, MnO-labeled cells produced "positive contrast" with an increased R1. Simultaneous imaging of both transplants with opposite contrast offers a method for MR "double labeling" of different cell populations.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalMagnetic resonance in medicine
Issue number1
StatePublished - Jul 2008


  • Cellular imaging
  • Contrast agent
  • Iron oxide
  • Manganese oxide
  • Nanoparticles
  • Transplantation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles'. Together they form a unique fingerprint.

Cite this